
Ocrevus (Ocrelizumab): A Guide to Intravenous MS Therapy
Out of Stock

Novantrone (Mitoxantrone): Chemotherapy-Based MS Infusion
Out of Stock

Tysabri (Natalizumab): Targeting Immune Cell Migration in MS
Out of Stock

Lemtrada (Alemtuzumab): A Potent IV Option for Multiple Sclerosis
Out of Stock

Glatopa (Glatiramer Acetate): A Generic Spin on Copaxone
Out of Stock

Betaseron (Interferon beta-1b): An Early Breakthrough in Injectable MS Care
Out of Stock

Avonex (Interferon beta-1a): A Once-Weekly MS Injection
Out of Stock

Kesimpta (Ofatumumab): A B-Cell Depleting Injection for MS
Out of Stock

Copaxone (Glatiramer Acetate): A Long-Standing MS Injection
Out of Stock

Extavia (Interferon beta-1b): Another Path in Interferon-Based Therapy
Out of Stock

Rebif (Interferon beta-1a): A Tried--True MS Injection
Out of Stock

Aubagio (Teriflunomide): An Oral Immunomodulator for MS
Out of Stock

Plegridy (Peginterferon beta-1a): Extended-Dosing Interferon for MS
Out of Stock

Maenclad (Mavenclad / Cladribine): Short-Course Oral MS Therapy
Out of Stock

Gilenya (Fingolimod): A Sphingosine 1-Phosphate Receptor Modulator
Out of Stock

Mayzent (Siponimod): An S1P Modulator for Secondary Progressive MS
Out of Stock

Ponvory (Ponesimod): A Next-Gen S1P Receptor Modulator
Out of Stock

Tascenso ODT (Fingolimod): The Orally Disintegrating Tablet for MS
Out of Stock

Tecfidera (Dimethyl fumarate): A Fumarate Pioneer in Oral MS Treatment
Out of Stock

Zeposia (Ozanimod): A Selective S1P Receptor Modulator for MS
Out of Stock

Vumerity (Diroximel fumarate): A Gentler Fumarate for MS
Out of Stock